ABSTRACT
The broad substrate capacity of the intestinal oligopeptide transporter, PepT1, has made it a key target of research into drug delivery. Whilst the substrate capacity of this transporter is broad, studies have largely been limited to small peptides and peptide-like drugs. Here, we demonstrate for the first time that a diverse range of drugs can be targeted towards transport by PepT1 using a hydrolysis resistant carrier. Eleven prodrugs were synthesized by conjugating modified dipeptides containing a thioamide bond to the approved drugs ibuprofen, gabapentin, propofol, aspirin, acyclovir, nabumetone, atenolol, zanamivir, baclofen and mycophenolate. Except for the aspirin and acyclovir prodrugs, which were unstable in the assay conditions and were not further studied, the prodrugs were tested for affinity and transport by PepT1 expressed in Xenopus laevis oocytes: binding affinities ranged from approximately 0.1 to 2â¯mM. Compounds which showed robust transport in an oocyte trans-stimulation assay were then tested for transcellular transport in Caco-2â¯cell monolayers: all five tested prodrugs showed significant PepT1-mediated transcellular uptake. Finally, the ibuprofen and propofol prodrugs were tested for absorption in rats: following oral dosing the intact prodrugs and free ibuprofen were measured in the plasma. This provides proof-of-concept for the idea of targeting poorly bioavailable drugs towards PepT1 transport as a general means of improving oral permeability.
Subject(s)
Dipeptides/metabolism , Drug Carriers/metabolism , Drug Delivery Systems , Intestinal Mucosa/metabolism , Peptide Transporter 1/metabolism , Prodrugs/metabolism , Thioamides/metabolism , Animals , Caco-2 Cells , Dipeptides/chemistry , Drug Carriers/chemistry , Humans , Intestinal Absorption , Male , Prodrugs/chemistry , Prodrugs/pharmacokinetics , Rats , Rats, Sprague-Dawley , Thioamides/chemistry , Xenopus laevisABSTRACT
In addition to being responsible for the majority of absorption of dietary nitrogen, the mammalian proton-coupled di- and tri-peptide transporter PepT1 is also recognised as a major route of drug delivery for several important classes of compound, including beta-lactam antibiotics and angiotensin-converting enzyme inhibitors. Thus there is considerable interest in the PepT1 protein and especially its substrate binding site. In the absence of a crystal structure, computer modelling has been used to try to understand the relationship between PepT1 3D structure and function. Two basic approaches have been taken: modelling the transporter protein, and modelling the substrate. For the former, computer modelling has evolved from early interpretations of the twelve transmembrane domain structure to more recent homology modelling based on recently crystallised bacterial members of the major facilitator superfamily (MFS). Substrate modelling has involved the proposal of a substrate binding template, to which all substrates must conform and from which the affinity of a substrate can be estimated relatively accurately, and identification of points of potential interaction of the substrate with the protein by developing a pharmacophore model of the substrates. Most recently, these two approaches have moved closer together, with the attempted docking of a substrate library onto a homology model of the human PepT1 protein. This article will review these two approaches in which computers have been applied to peptide transport and suggest how such computer modelling could affect drug design and delivery through PepT1.
Subject(s)
Computer Simulation , Dipeptides/chemical synthesis , Dipeptides/metabolism , Drug Design , Pharmaceutical Preparations/chemical synthesis , Pharmaceutical Preparations/metabolism , Symporters/chemical synthesis , Symporters/metabolism , Animals , Biological Availability , Humans , Peptide Transporter 1 , Protein BindingABSTRACT
Cycloaddition of pyridine N-imine with 6-alkyl-4-oxohex-5-ynoates followed by condensation with hydrazine provides concise access to pharmacologically active 6-(pyrazolo[1,5-a]pyridin-3-yl)pyridazinones. For the first time alkynyl heterocycles are also shown to be effective dipolarophiles for pyridine N-imine, and analogous compounds can be accessed directly in modest yields through the reaction of 6-(alkyn-1-yl)pyridazin-3-one derivatives.
Subject(s)
Pyrazoles/chemistry , Pyrazoles/chemical synthesis , Pyridines/chemistry , Pyridines/chemical synthesis , Crystallography, X-Ray , Hydrazines/chemistry , Imines/chemistryABSTRACT
A quantitative method has been developed for determining the affinity of substrates for the peptide transporter PepT1, allowing oral availability of drugs via PepT1 to be estimated.
Subject(s)
Algorithms , Peptides/chemistry , Symporters/chemistry , Binding Sites , Biological Transport , Molecular Structure , Peptide Transporter 1 , Peptides/metabolism , Substrate Specificity , Symporters/metabolismABSTRACT
The stereochemistry of thiodipeptides of proline [e.g. Ala-Psi[CS-N]-Pro] can be controlled using pH, allowing the trans-preference for substrates of the peptide transporter PepT1 to be confirmed.
Subject(s)
Membrane Transport Proteins/chemistry , Peptides/chemistry , Sulfhydryl Compounds/chemistry , Hydrogen-Ion Concentration , Magnetic Resonance Spectroscopy , Membrane Transport Proteins/metabolism , Molecular Structure , Peptides/metabolism , StereoisomerismABSTRACT
The conformation at the first residue of dipeptide substrates for the peptide transporter PepT1 has been probed using constrained peptide analogues, and the active conformation has been identified.
Subject(s)
Dipeptides/chemistry , Symporters/chemistry , Models, Molecular , Peptide Transporter 1 , Protein Conformation , Substrate SpecificityABSTRACT
The total synthesis of (-)-raumacline from L-tryptophan was achieved, featuring a cis-specific Pictet-Spengler reaction, a stereoselective Dieckmann cyclization, and an epimerization step that allowed complete stereocontrol of five chiral centres.
